{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:45:59Z","timestamp":1787726759541,"version":"build-2784847793"},"publisher-location":"New York, NY","reference-count":83,"publisher":"Springer US","isbn-type":[{"value":"9781071651117","type":"print"},{"value":"9781071651124","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5112-4_7","type":"book-chapter","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T22:05:51Z","timestamp":1785621951000},"page":"93-118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intelligence Disclosure on Deploying SpyTag\/SpyCatcher for Nanoparticle Assembly"],"prefix":"10.1007","author":[{"given":"Rory A.","family":"Hills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"8","key":"7_CR1","doi-asserted-by":"publisher","first-page":"2104012","DOI":"10.1002\/advs.202104012","volume":"9","author":"N Habibi","year":"2022","unstructured":"Habibi N, Mauser A, Ko Y, Lahann J (2022) Protein nanoparticles: uniting the power of proteins with engineering design approaches. Adv Sci 9(8):2104012. https:\/\/doi.org\/10.1002\/advs.202104012","journal-title":"Adv Sci"},{"issue":"44","key":"7_CR2","doi-asserted-by":"publisher","first-page":"202216097","DOI":"10.1002\/anie.202216097","volume":"62","author":"J Kaltbeitzel","year":"2023","unstructured":"Kaltbeitzel J, Wich PR (2023) Protein-based nanoparticles: from drug delivery to imaging, nanocatalysis and protein therapy. Angew Chem 62(44):202216097. https:\/\/doi.org\/10.1002\/anie.202216097","journal-title":"Angew Chem"},{"issue":"7610","key":"7_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nature18010","volume":"535","author":"Y Hsia","year":"2016","unstructured":"Hsia Y, Bale JB, Gonen S, Shi D, Sheffler W, Fong KK, Nattermann U, Xu C, Huang PS, Ravichandran R, Yi S, Davis TN, Gonen T, King NP, Baker D (2016) Design of a hyperstable 60-subunit protein icosahedron. Nature 535(7610):136\u2013139. https:\/\/doi.org\/10.1038\/nature18010","journal-title":"Nature"},{"issue":"9","key":"7_CR4","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1007\/s00253-020-10483-5","volume":"104","author":"J Wang","year":"2020","unstructured":"Wang J, Liu Y, Chen Y, Wang A, Wei Q, Liu D, Zhang G (2020) Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation. Appl Microbiol Biotechnol 104(9):3847\u20133857. https:\/\/doi.org\/10.1007\/s00253-020-10483-5","journal-title":"Appl Microbiol Biotechnol"},{"issue":"12","key":"7_CR5","doi-asserted-by":"publisher","first-page":"110143","DOI":"10.1016\/j.celrep.2021.110143","volume":"37","author":"MG Joyce","year":"2021","unstructured":"Joyce MG, Chen W-H, Sankhala RS, Hajduczki A, Thomas PV, Choe M, Martinez EJ, Chang WC, Peterson CE, Morrison EB, Smith C, Chen RE, Ahmed A, Wieczorek L, Anderson A, Case JB, Li Y, Oertel T, Rosado L, Modjarrad K (2021) SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Cell Rep 37(12):110143. https:\/\/doi.org\/10.1016\/j.celrep.2021.110143","journal-title":"Cell Rep"},{"issue":"6","key":"7_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2666-5247(23)00410-X","volume":"5","author":"BL Ober Shepherd","year":"2024","unstructured":"Ober Shepherd BL, Scott PT, Hutter JN, Lee C, McCauley MD, Guzman I, Bryant C, McGuire S, Kennedy J, Chen W-H, Hajduczki A, Mdluli T, Valencia-Ruiz A, Amare MF, Matyas GR, Rao M, Rolland M, Mascola JR, Rosa SC, Gazi M (2024) SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with army liposome formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial. Lancet Microbe 5(6):581\u2013593. https:\/\/doi.org\/10.1016\/S2666-5247(23)00410-X","journal-title":"Lancet Microbe"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3389\/fimmu.2018.01432","volume":"9","author":"KD Brune","year":"2018","unstructured":"Brune KD, Howarth M (2018) New routes and opportunities for modular construction of particulate vaccines: stick, click, and glue. Front Immunol 9:1432. https:\/\/doi.org\/10.3389\/fimmu.2018.01432","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"7_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/protein\/gzq069","volume":"24","author":"MG Mateu","year":"2011","unstructured":"Mateu MG (2011) Virus engineering: functionalization and stabilization. Protein Eng Des Sel 24(1\u20132):53\u201363. https:\/\/doi.org\/10.1093\/protein\/gzq069","journal-title":"Protein Eng Des Sel"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"19234","DOI":"10.1038\/srep19234","volume":"6","author":"KD Brune","year":"2016","unstructured":"Brune KD, Leneghan DB, Brian IJ, Ishizuka AS, Bachmann MF, Draper SJ, Biswas S, Howarth M (2016) Plug-and-display: decoration of virus-like particles via isopeptide bonds for modular immunization. Sci Rep 6:19234. https:\/\/doi.org\/10.1038\/srep19234","journal-title":"Sci Rep"},{"issue":"1","key":"7_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12951-016-0181-1","volume":"14","author":"S Thrane","year":"2016","unstructured":"Thrane S, Janitzek CM, Matondo S, Resende M, Gustavsson T, Jongh WA, Clemmensen S, Roeffen W, Vegte Bolmer M, Gemert GJ, Sauerwein R, Schiller JT, Nielsen MA, Theander TG, Salanti A, Sander AF (2016) Bacterial superglue enables easy development of efficient virus-like particle based vaccines. J Nanobiotechnol 14(1):30. https:\/\/doi.org\/10.1186\/s12951-016-0181-1","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"7_CR11","doi-asserted-by":"publisher","first-page":"E690","DOI":"10.1073\/pnas.1115485109","volume":"109","author":"B Zakeri","year":"2012","unstructured":"Zakeri B, Fierer JO, Celik E, Chittock EC, Schwarz-Linek U, Moy VT, Howarth M (2012) Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc Natl Acad Sci 109(12):E690\u2013E697. https:\/\/doi.org\/10.1073\/pnas.1115485109","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"7_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","volume":"21","author":"AJ Pollard","year":"2021","unstructured":"Pollard AJ, Bijker EM (2021) A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 21(2):83\u2013100. https:\/\/doi.org\/10.1038\/s41577-020-00479-7","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"7_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann MF, Jennings GT (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 10(11):787\u2013796. https:\/\/doi.org\/10.1038\/nri2868","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"7_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0132-6","volume":"4","author":"C Herv\u00e9","year":"2019","unstructured":"Herv\u00e9 C, Laup\u00e8ze B, Del Giudice G, Didierlaurent AM, Silva F (2019) The how\u2019s and what\u2019s of vaccine reactogenicity. NPJ Vaccines 4(1):39. https:\/\/doi.org\/10.1038\/s41541-019-0132-6","journal-title":"NPJ Vaccines"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.copbio.2021.09.012","volume":"73","author":"RA Hills","year":"2022","unstructured":"Hills RA, Howarth M (2022) Virus-like particles against infectious disease and cancer: guidance for the nano-architect. Curr Opin Biotechnol 73:346\u2013354. https:\/\/doi.org\/10.1016\/j.copbio.2021.09.012","journal-title":"Curr Opin Biotechnol"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.sbi.2017.03.007","volume":"43","author":"JG Heddle","year":"2017","unstructured":"Heddle JG, Chakraborti S, Iwasaki K (2017) Natural and artificial protein cages: design, structure and therapeutic applications. Curr Opin Struct Biol 43:148\u2013155. https:\/\/doi.org\/10.1016\/j.sbi.2017.03.007","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"7_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/vaccines5010006","volume":"5","author":"A Gomes","year":"2017","unstructured":"Gomes A, Mohsen M, Bachmann M (2017) Harnessing nanoparticles for immunomodulation and vaccines. Vaccines 5(1):6. https:\/\/doi.org\/10.3390\/vaccines5010006","journal-title":"Vaccines"},{"issue":"1","key":"7_CR18","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1080\/22221751.2020.1760735","volume":"9","author":"NMA Okba","year":"2020","unstructured":"Okba NMA, Widjaja I, Dieren B, Aebischer A, Amerongen G, Waal L, Stittelaar KJ, Schipper D, Martina B, Brand JMA, Beer M, Bosch B-J, Haagmans BL (2020) Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV. Emerg Microbes Infect 9(1):1080\u20131091. https:\/\/doi.org\/10.1080\/22221751.2020.1760735","journal-title":"Emerg Microbes Infect"},{"issue":"11","key":"7_CR19","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1126\/sciadv.abl6015","volume":"8","author":"NC Dalvie","year":"2022","unstructured":"Dalvie NC, Tostanoski LH, Rodriguez-Aponte SA, Kaur K, Bajoria S, Kumru OS, Martinot AJ, Chandrashekar A, McMahan K, Mercado NB, Yu J, Chang A, Giffin VM, Nampanya F, Patel S, Bowman L, Naranjo CA, Yun D, Flinchbaugh Z, Barouch DH (2022) SARS-CoV-2 receptor binding domain displayed on HBsAg virus\u2013like particles elicits protective immunity in macaques. Sci Adv 8(11):6015. https:\/\/doi.org\/10.1126\/sciadv.abl6015","journal-title":"Sci Adv"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"102223","DOI":"10.1016\/j.nano.2020.102223","volume":"28","author":"M Ji","year":"2020","unstructured":"Ji M, Zhu J, Xie X, Liu D, Wang B, Yu Z, Liu R (2020) A novel rapid modularized hepatitis B core virus-like particle-based platform for personalized cancer vaccine preparation via fixed-point coupling. Nanomed Nanotechnol Biol Med 28:102223. https:\/\/doi.org\/10.1016\/j.nano.2020.102223","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"1","key":"7_CR21","doi-asserted-by":"publisher","first-page":"108937","DOI":"10.1016\/j.celrep.2021.108937","volume":"35","author":"AR Corrigan","year":"2021","unstructured":"Corrigan AR, Duan H, Cheng C, Gonelli CA, Ou L, Xu K, DeMouth ME, Geng H, Narpala S, O\u2019Connell S, Zhang B, Zhou T, Basappa M, Boyington JC, Chen SJ, O\u2019Dell S, Pegu A, Stephens T, Tsybovsky Y, Mascola JR (2021) Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base. Cell Rep 35(1):108937. https:\/\/doi.org\/10.1016\/j.celrep.2021.108937","journal-title":"Cell Rep"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nano.2018.11.009","volume":"16","author":"W Wang","year":"2019","unstructured":"Wang W, Liu Z, Zhou X, Guo Z, Zhang J, Zhu P, Yao S, Zhu M (2019) Ferritin nanoparticle-based spytag\/spycatcher-enabled click vaccine for tumor immunotherapy. Nanomed Nanotechnol Biol Med 16:69\u201378. https:\/\/doi.org\/10.1016\/j.nano.2018.11.009","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"1","key":"7_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12951-023-02210-9","volume":"21","author":"J Song","year":"2023","unstructured":"Song J, Wang M, Zhou L, Tian P, Sun Z, Sun J, Wang X, Zhuang G, Jiang D, Wu Y, Zhang G (2023) A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response. J Nanobiotechnology 21(1):424. https:\/\/doi.org\/10.1186\/s12951-023-02210-9","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"7_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12951-022-01710-4","volume":"20","author":"Z-H Liu","year":"2022","unstructured":"Liu Z-H, Deng Z-F, Lu Y, Fang W-H, He F (2022) A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles. J Nanobiotechnology 20(1):493. https:\/\/doi.org\/10.1186\/s12951-022-01710-4","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"7_CR25","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s10126-022-10166-4","volume":"24","author":"JI Yang","year":"2022","unstructured":"Yang JI, Kim KH (2022) Display of Streptococcus iniae \u03b1-enolase on the surface of virus-like particles (VLPs) of nervous necrosis virus (NNV) using SpyTag\/SpyCatcher. Mar Biotechnol 24(6):1066\u20131072. https:\/\/doi.org\/10.1007\/s10126-022-10166-4","journal-title":"Mar Biotechnol"},{"issue":"1","key":"7_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/anie.202009663","volume":"60","author":"R Rahikainen","year":"2021","unstructured":"Rahikainen R, Rijal P, Tan TK, Wu HJ, Andersson AMC, Barrett JR, Bowden TA, Draper SJ, Townsend AR, Howarth M (2021) Overcoming symmetry mismatch in vaccine nanoassembly through spontaneous amidation. Angew Chem 60(1):321\u2013330. https:\/\/doi.org\/10.1002\/anie.202009663","journal-title":"Angew Chem"},{"issue":"1","key":"7_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12934-023-02099-x","volume":"22","author":"Y Liu","year":"2023","unstructured":"Liu Y, Pan C, Wang K, Guo Y, Sun Y, Li X, Sun P, Wu J, Wang H, Zhu L (2023) Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli. Microb Cell Factories 22(1):95. https:\/\/doi.org\/10.1186\/s12934-023-02099-x","journal-title":"Microb Cell Factories"},{"issue":"43","key":"7_CR28","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.1016\/j.vaccine.2019.09.004","volume":"37","author":"ML Govasli","year":"2019","unstructured":"Govasli ML, Diaz Y, Puntervoll P (2019) Virus-like particle-display of the enterotoxigenic Escherichia coli heat-stable toxoid STh-A14T elicits neutralizing antibodies in mice. Vaccine 37(43):6405\u20136414. https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.004","journal-title":"Vaccine"},{"issue":"1","key":"7_CR29","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1038\/s41467-025-59826-8","volume":"16","author":"AA Belghith","year":"2025","unstructured":"Belghith AA, Cotter CA, Ignacio MA, Earl PL, Hills RA, Howarth MR, Yee DS, Brenchley JM, Moss B (2025) Mpox Multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates. Nat Commun 16(1):4726. https:\/\/doi.org\/10.1038\/s41467-025-59826-8","journal-title":"Nat Commun"},{"issue":"2","key":"7_CR30","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s12274-021-3713-4","volume":"15","author":"X Li","year":"2022","unstructured":"Li X, Pan C, Sun P, Peng Z, Feng E, Wu J, Wang H, Zhu L (2022) Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection. Nano Res 15(2):1645\u20131653. https:\/\/doi.org\/10.1007\/s12274-021-3713-4","journal-title":"Nano Res"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"1204834","DOI":"10.3389\/fimmu.2023.1204834","volume":"14","author":"M Gonzalez-Hernandez","year":"2023","unstructured":"Gonzalez-Hernandez M, Kaiser FK, Steffen I, Ciurkiewicz M, Amerongen G, Tchelet R, Emalfarb M, Saloheimo M, Wiebe MG, Vitikainen M, Albulescu IC, Bosch B-J, Baumg\u00e4rtner W, Haagmans BL, Osterhaus ADME (2023) Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system thermothelomyces heterothallica C1. Front Immunol 14:1204834. https:\/\/doi.org\/10.3389\/fimmu.2023.1204834","journal-title":"Front Immunol"},{"issue":"5","key":"7_CR32","doi-asserted-by":"publisher","first-page":"0181321","DOI":"10.1128\/mBio.01813-21","volume":"12","author":"L Oosten","year":"2021","unstructured":"Oosten L, Altenburg JJ, Fougeroux C, Geertsema C, End F, Evers WAC, Westphal AH, Lindhoud S, Berg W, Swarts DC, Deurhof L, Suhrbier A, Le TT, Torres Morales S, Myeni SK, Kikkert M, Sander AF, Jongh WA, Dagil R, Pijlman GP (2021) Two-component nanoparticle vaccine displaying glycosylated spike s1 domain induces neutralizing antibody response against SARS-CoV-2 variants. mBio 12(5):0181321. https:\/\/doi.org\/10.1128\/mBio.01813-21","journal-title":"mBio"},{"issue":"9","key":"7_CR33","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","volume":"12","author":"TUJ Bruun","year":"2018","unstructured":"Bruun TUJ, Andersson AMC, Draper SJ, Howarth M (2018) Engineering a rugged nanoscaffold to enhance plug-and-display vaccination. ACS Nano 12(9):8855\u20138866. https:\/\/doi.org\/10.1021\/acsnano.8b02805","journal-title":"ACS Nano"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"1096363","DOI":"10.3389\/fbioe.2023.1096363","volume":"11","author":"J Xu","year":"2023","unstructured":"Xu J, Sekiguchi T, Boonyakida J, Kato T, Park EY (2023) Display of multiple proteins on engineered canine parvovirus-like particles expressed in cultured silkworm cells and silkworm larvae. Front Bioeng Biotechnol 11:1096363.\u2002https:\/\/doi.org\/10.3389\/fbioe.2023.1096363","journal-title":"Front Bioeng Biotechnol"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"738619","DOI":"10.3389\/fpls.2021.738619","volume":"12","author":"J Stander","year":"2021","unstructured":"Stander J, Chabeda A, Rybicki EP, Meyers AE (2021) A plant-produced virus-like particle displaying envelope protein domain III elicits an immune response against West Nile virus in mice. Front Plant Sci 12:738619. https:\/\/doi.org\/10.3389\/fpls.2021.738619","journal-title":"Front Plant Sci"},{"issue":"4","key":"7_CR36","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1021\/acsnano.2c08840","volume":"17","author":"P Zheng","year":"2023","unstructured":"Zheng P, Yang Y, Fu Y, He J, Hu Y, Zheng X, Duan B, Wang M, Liu Q, Li W, Li D, Yang Y, Yang Z, Yang X, Huang W, Ma Y (2023) Engineered norovirus-derived nanoparticles as a plug-and-play cancer vaccine platform. ACS Nano 17(4):3412\u20133429. https:\/\/doi.org\/10.1021\/acsnano.2c08840","journal-title":"ACS Nano"},{"issue":"4","key":"7_CR37","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/all.15892","volume":"79","author":"S Chanasit","year":"2024","unstructured":"Chanasit S, Johnston E, Thanasarnthungcharoen C, Kamath SD, Bohle B, Lopata AL, Jacquet A (2024) Hypoallergenic chimeric virus-like particles for the development of shrimp tropomyosin allergen Pen m 1-specific blocking antibodies. Allergy 79(4):1052\u20131055. https:\/\/doi.org\/10.1111\/all.15892","journal-title":"Allergy"},{"issue":"4","key":"7_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/vaccines10040485","volume":"10","author":"A Ogrina","year":"2022","unstructured":"Ogrina A, Skrastina D, Balke I, Kalnciema I, Jansons J, Bachmann MF, Zeltins A (2022) Comparison of bacterial expression systems based on potato virus Y-like particles for vaccine generation. Vaccines 10(4):485. https:\/\/doi.org\/10.3390\/vaccines10040485","journal-title":"Vaccines"},{"issue":"1","key":"7_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/vaccines11010002","volume":"11","author":"L Goks\u00f8yr","year":"2022","unstructured":"Goks\u00f8yr L, Skrzypczak M, Sampson M, Nielsen MA, Salanti A, Theander TG, Remaley AT, Jongh WA, Sander AF (2022) A cVLP-based vaccine displaying full-length PCSK9 elicits a higher reduction in plasma PCSK9 than similar peptide-based cVLP vaccines. Vaccines 11(1):2. https:\/\/doi.org\/10.3390\/vaccines11010002","journal-title":"Vaccines"},{"key":"7_CR40","unstructured":"SpyBiotech Limited (2014) A study of human cytomegalovirus (HCMV) vaccine SPYVLP01 with and without adjuvants. SPYVAC01.\u2002https:\/\/clinicaltrials.gov\/study\/NCT06145178"},{"issue":"7","key":"7_CR41","doi-asserted-by":"publisher","first-page":"101654","DOI":"10.1016\/j.xcrm.2024.101654","volume":"5","author":"LDW King","year":"2024","unstructured":"King LDW, Pulido D, Barrett JR, Davies H, Quinkert D, Lias AM, Silk SE, Pattinson DJ, Diouf A, Williams BG, McHugh K, Rodrigues A, Rigby CA, Strazza V, Suurbaar J, Rees-Spear C, Dabbs RA, Ishizuka AS, Zhou Y, Draper SJ (2024) Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies. Cell Rep Med 5(7):101654. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101654","journal-title":"Cell Rep Med"},{"issue":"3","key":"7_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S2666-5247(22)00337-8","volume":"4","author":"MJ Smit","year":"2023","unstructured":"Smit MJ, Sander AF, Ariaans MBPA, Fougeroux C, Heinzel C, Fendel R, Esen M, Kremsner PG, Heine R, Wertheim HF, Idorn M, Paludan SR, Underwood AP, Binderup A, Ramirez S, Bukh J, Soegaard M, Erdogan SM, Gustavsson T, Vidal-Calvo E (2023) First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2. Lancet Microbe 4(3):140\u2013148. https:\/\/doi.org\/10.1016\/S2666-5247(22)00337-8","journal-title":"Lancet Microbe"},{"issue":"52","key":"7_CR43","doi-asserted-by":"publisher","first-page":"26523","DOI":"10.1073\/pnas.1909653116","volume":"116","author":"AH Keeble","year":"2019","unstructured":"Keeble AH, Turkki P, Stokes S, Khairil Anuar INA, Rahikainen R, Hyt\u00f6nen VP, Howarth M (2019) Approaching infinite affinity through engineering of peptide\u2013protein interaction. Proc Natl Acad Sci 116(52):26523\u201326533. https:\/\/doi.org\/10.1073\/pnas.1909653116","journal-title":"Proc Natl Acad Sci"},{"issue":"28","key":"7_CR44","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1039\/d0sc01878c","volume":"11","author":"AH Keeble","year":"2020","unstructured":"Keeble AH, Howarth M (2020) Power to the protein: enhancing and combining activities using the spy toolbox. Chem Sci 11(28):7281\u20137291. https:\/\/doi.org\/10.1039\/d0sc01878c","journal-title":"Chem Sci"},{"issue":"9","key":"7_CR45","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/elps.201800219","volume":"40","author":"P Tiwari","year":"2019","unstructured":"Tiwari P, Kaila P, Guptasarma P (2019) Understanding anomalous mobility of proteins on SDS-PAGE with special reference to the highly acidic extracellular domains of human E- and N-cadherins. Electrophoresis 40(9):1273\u20131281. https:\/\/doi.org\/10.1002\/elps.201800219","journal-title":"Electrophoresis"},{"issue":"50","key":"7_CR46","doi-asserted-by":"publisher","first-page":"11834","DOI":"10.1021\/bi901756n","volume":"48","author":"J Huang","year":"2009","unstructured":"Huang J, Nagy SS, Koide A, Rock RS, Koide S (2009) A peptide tag system for facile purification and single-molecule immobilization. Biochemistry 48(50):11834\u201311836. https:\/\/doi.org\/10.1021\/bi901756n","journal-title":"Biochemistry"},{"issue":"8","key":"7_CR47","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41565-024-01655-9","volume":"19","author":"RA Hills","year":"2024","unstructured":"Hills RA, Tan TK, Cohen AA, Keeffe JR, Keeble AH, Gnanapragasam PNP, Storm KN, Rorick AV, West AP, Hill ML, Liu S, Gilbert-Jaramillo J, Afzal M, Napier A, Admans G, James WS, Bjorkman PJ, Townsend AR, Howarth MR (2024) Proactive vaccination using multiviral quartet nanocages to elicit broad anti-coronavirus responses. Nat Nanotechnol 19(8):1216\u20131223. https:\/\/doi.org\/10.1038\/s41565-024-01655-9","journal-title":"Nat Nanotechnol"},{"issue":"44","key":"7_CR48","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1016\/j.vaccine.2022.09.058","volume":"40","author":"H Zhu","year":"2022","unstructured":"Zhu H, Li X, Ren X, Chen H, Qian P (2022) Improving cross-protection against influenza virus in mice using a nanoparticle vaccine of mini-HA. Vaccine 40(44):6352\u20136361. https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.058","journal-title":"Vaccine"},{"issue":"1","key":"7_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-31193-8","volume":"13","author":"SK Vester","year":"2022","unstructured":"Vester SK, Rahikainen R, Khairil Anuar INA, Hills RA, Tan TK, Howarth M (2022) SpySwitch enables pH- or heat-responsive capture and release for plug-and-display nanoassembly. Nat Commun 13(1):1\u201316. https:\/\/doi.org\/10.1038\/s41467-022-31193-8","journal-title":"Nat Commun"},{"issue":"2","key":"7_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.chembiol.2021.07.005","volume":"29","author":"AH Keeble","year":"2022","unstructured":"Keeble AH, Yadav VK, Ferla MP, Bauer CC, Chuntharpursat-Bon E, Huang J, Bon RS, Howarth M (2022) DogCatcher allows loop-friendly protein-protein ligation. Cell Chem Biol 29(2):339\u2013350.e10. https:\/\/doi.org\/10.1016\/j.chembiol.2021.07.005","journal-title":"Cell Chem Biol"},{"issue":"6","key":"7_CR51","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/vaccines9060651","volume":"9","author":"A Aebischer","year":"2021","unstructured":"Aebischer A, Wernike K, K\u00f6nig P, Franzke K, Wichgers Schreur PJ, Kortekaas J, Vitikainen M, Wiebe M, Saloheimo M, Tchelet R, Audonnet J-C, Beer M (2021) Development of a modular vaccine platform for multimeric antigen display using an orthobunyavirus model. Vaccines 9(6):651. https:\/\/doi.org\/10.3390\/vaccines9060651","journal-title":"Vaccines"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.3389\/fimmu.2019.02931","volume":"10","author":"A Marini","year":"2019","unstructured":"Marini A, Zhou Y, Li Y, Taylor IJ, Leneghan DB, Jin J, Zaric M, Mekhaiel D, Long CA, Miura K, Biswas S (2019) A universal plug-and-display vaccine carrier based on HBsAg VLP to maximize effective antibody response. Front Immunol 10:2931. https:\/\/doi.org\/10.3389\/fimmu.2019.02931","journal-title":"Front Immunol"},{"issue":"1","key":"7_CR53","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41467-020-20654-7","volume":"12","author":"TK Tan","year":"2021","unstructured":"Tan TK, Rijal P, Rahikainen R, Keeble AH, Schimanski L, Hussain S, Harvey R, Hayes JWP, Edwards JC, McLean RK, Martini V, Pedrera M, Thakur N, Conceicao C, Dietrich I, Shelton H, Ludi A, Wilsden G, Browning C, Townsend AR (2021) A COVID-19 vaccine candidate using spycatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. Nat Commun 12(1):542. https:\/\/doi.org\/10.1038\/s41467-020-20654-7","journal-title":"Nat Commun"},{"issue":"6530","key":"7_CR54","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.abf6840","volume":"371","author":"AA Cohen","year":"2021","unstructured":"Cohen AA, Gnanapragasam PNP, Lee YE, Hoffman PR, Ou S, Kakutani LM, Keeffe JR, Wu H-J, Howarth M, West AP, Barnes CO, Nussenzweig MC, Bjorkman PJ (2021) Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science 371(6530):735\u2013741. https:\/\/doi.org\/10.1126\/science.abf6840","journal-title":"Science"},{"issue":"1","key":"7_CR55","doi-asserted-by":"publisher","first-page":"2511132","DOI":"10.1080\/22221751.2025.2511132","volume":"14","author":"CQ Huang","year":"2025","unstructured":"Huang CQ, Hills RA, Carnell GW, Vishwanath S, Aguinam ET, Chan ACY, Palmer P, O\u2019Reilly L, Tonks P, Temperton N, Frost SDW, Tiley LS, Howarth MR, Heeney JL (2025) Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses. Emerg Microbes Infect 14(1):2511132. https:\/\/doi.org\/10.1080\/22221751.2025.2511132","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"7_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","volume":"71","author":"CRH Raetz","year":"2002","unstructured":"Raetz CRH, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71(1):635\u2013700. https:\/\/doi.org\/10.1146\/annurev.biochem.71.110601.135414","journal-title":"Annu Rev Biochem"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.toxicon.2017.10.016","volume":"149","author":"J-M Cavaillon","year":"2018","unstructured":"Cavaillon J-M (2018) Exotoxins and endotoxins: inducers of inflammatory cytokines. Toxicon 149:45\u201353.\u2002https:\/\/doi.org\/10.1016\/j.toxicon.2017.10.016","journal-title":"Toxicon"},{"issue":"12","key":"7_CR58","doi-asserted-by":"publisher","first-page":"113840","DOI":"10.1371\/journal.pone.0113840","volume":"9","author":"H Schwarz","year":"2014","unstructured":"Schwarz H, Schmittner M, Duschl A, Horejs-Hoeck J (2014) Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells. PLoS One 9(12):113840. https:\/\/doi.org\/10.1371\/journal.pone.0113840","journal-title":"PLoS One"},{"issue":"1","key":"7_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/jps.22267","volume":"100","author":"LA Brito","year":"2011","unstructured":"Brito LA, Singh M (2011) Acceptable levels of endotoxin in vaccine formulations during preclinical research. J Pharm Sci 100(1):34\u201337. https:\/\/doi.org\/10.1002\/jps.22267","journal-title":"J Pharm Sci"},{"issue":"1","key":"7_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12934-015-0241-5","volume":"14","author":"U Mamat","year":"2015","unstructured":"Mamat U, Wilke K, Bramhill D, Schromm AB, Lindner B, Kohl TA, Corchero JL, Villaverde A, Schaffer L, Head SR, Souvignier C, Meredith TC, Woodard RW (2015) Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins. Microb Cell Factories 14(1):57. https:\/\/doi.org\/10.1186\/s12934-015-0241-5","journal-title":"Microb Cell Factories"},{"issue":"8","key":"7_CR61","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1002\/bit.27362","volume":"117","author":"M Schneier","year":"2020","unstructured":"Schneier M, Razdan S, Miller AM, Briceno ME, Barua S (2020) Current technologies to endotoxin detection and removal for biopharmaceutical purification. Biotechnol Bioeng 117(8):2588\u20132609. https:\/\/doi.org\/10.1002\/bit.27362","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"7_CR62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0022-1759(90)90029-U","volume":"132","author":"Y Aida","year":"1990","unstructured":"Aida Y, Pabst MJ (1990) Removal of endotoxin from protein solutions by phase separation using triton X-114. J Immunol Methods 132(2):191\u2013195. https:\/\/doi.org\/10.1016\/0022-1759(90)90029-U","journal-title":"J Immunol Methods"},{"key":"7_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2023.11.001","volume":"118","author":"P Sondhi","year":"2024","unstructured":"Sondhi P, Adeniji T, Lingden D, Stine KJ (2024) Advances in endotoxin analysis. Adv Clin Chem 118:1\u201334. https:\/\/doi.org\/10.1016\/bs.acc.2023.11.001","journal-title":"Adv Clin Chem"},{"issue":"4","key":"7_CR64","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/2211068215572136","volume":"20","author":"W Su","year":"2015","unstructured":"Su W, Ding X (2015) Methods of endotoxin detection. SLAS Technol 20(4):354\u2013364. https:\/\/doi.org\/10.1177\/2211068215572136","journal-title":"SLAS Technol"},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"114122","DOI":"10.1016\/j.jpba.2021.114122","volume":"201","author":"R Dash","year":"2021","unstructured":"Dash R, Rathore AS (2021) Freeze thaw and lyophilization induced alteration in mAb therapeutics: trastuzumab as a case study. J Pharm Biomed Anal 201:114122. https:\/\/doi.org\/10.1016\/j.jpba.2021.114122","journal-title":"J Pharm Biomed Anal"},{"key":"7_CR66","doi-asserted-by":"publisher","first-page":"110036","DOI":"10.1016\/j.eurpolymj.2020.110036","volume":"140","author":"AER Fayter","year":"2020","unstructured":"Fayter AER, Hasan M, Congdon TR, Kontopoulou I, Gibson MI (2020) Ice recrystallisation inhibiting polymers prevent irreversible protein aggregation during solvent-free cryopreservation as additives and as covalent polymer-protein conjugates. Eur Polym J 140:110036. https:\/\/doi.org\/10.1016\/j.eurpolymj.2020.110036","journal-title":"Eur Polym J"},{"issue":"10","key":"7_CR67","doi-asserted-by":"publisher","first-page":"105127","DOI":"10.1016\/j.isci.2022.105127","volume":"25","author":"N Kommineni","year":"2022","unstructured":"Kommineni N, Butreddy A, Sainaga Jyothi VGS, Angsantikul P (2022) Freeze-drying for the preservation of immunoengineering products. iScience 25(10):105127. https:\/\/doi.org\/10.1016\/j.isci.2022.105127","journal-title":"iScience"},{"issue":"621","key":"7_CR68","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1126\/scitranslmed.abk1533","volume":"13","author":"A Escolano","year":"2021","unstructured":"Escolano A, Gristick HB, Gautam R, DeLaitsch AT, Abernathy ME, Yang Z, Wang H, Hoffmann MAG, Nishimura Y, Wang Z, Koranda N, Kakutani LM, Gao H, Gnanapragasam PNP, Raina H, Gazumyan A, Cipolla M, Oliveira TY, Ramos V, Bjorkman PJ (2021) Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env. Sci Transl Med 13(621):1533. https:\/\/doi.org\/10.1126\/scitranslmed.abk1533","journal-title":"Sci Transl Med"},{"issue":"50","key":"7_CR69","doi-asserted-by":"publisher","first-page":"2302922","DOI":"10.1002\/smll.202302922","volume":"19","author":"P Zheng","year":"2023","unstructured":"Zheng P, He J, Yang Z, Fu Y, Yang Y, Li W, Ding Y, Yang X, Ma Y (2023) Neoantigen-based nanovaccine in combination with immune checkpoint inhibitors abolish postsurgical tumor recurrence and metastasis. Small 19(50):2302922. https:\/\/doi.org\/10.1002\/smll.202302922","journal-title":"Small"},{"issue":"3","key":"7_CR70","doi-asserted-by":"publisher","first-page":"0247963","DOI":"10.1371\/journal.pone.0247963","volume":"16","author":"AA Cohen","year":"2021","unstructured":"Cohen AA, Yang Z, Gnanapragasam PNP, Ou S, Dam K-MA, Wang H, Bjorkman PJ (2021) Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers. PLoS One 16(3):0247963.\u2002https:\/\/doi.org\/10.1371\/journal.pone.0247963","journal-title":"PLoS One"},{"issue":"34","key":"7_CR71","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1016\/j.vaccine.2023.06.080","volume":"41","author":"KS Lee","year":"2023","unstructured":"Lee KS, Rader NA, Miller-Stump OA, Cooper M, Wong TY, Amin S, M B, M B, R J, Ernst RK, Heath Damron F (2023) Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against delta SARS-CoV-2 challenge in K18-hACE2-mice. Vaccine 41(34):5003\u20135017. https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.080","journal-title":"Vaccine"},{"issue":"3","key":"7_CR72","doi-asserted-by":"publisher","first-page":"04998","DOI":"10.1128\/spectrum.04998-22","volume":"12","author":"DR Patel","year":"2024","unstructured":"Patel DR, Minns AM, Sim DG, Field CJ, Kerr AE, Heinly TA, Luley EH, Rossi RM, Bator CM, Moustafa IM, Norton EB, Hafenstein SL, Lindner SE, Sutton TC (2024) Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model. Microbiol Spectr 12(3):04998\u201322. https:\/\/doi.org\/10.1128\/spectrum.04998-22","journal-title":"Microbiol Spectr"},{"issue":"2","key":"7_CR73","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/vaccines9020131","volume":"9","author":"CM Janitzek","year":"2021","unstructured":"Janitzek CM, Carlsen PHR, Thrane S, Khanna VM, Jakob V, Barnier-Quer C, Collin N, Theander TG, Salanti A, Nielsen MA, Sander AF (2021) The immunogenicity of capsid-like particle vaccines in combination with different adjuvants using different routes of administration. Vaccines 9(2):131. https:\/\/doi.org\/10.3390\/vaccines9020131","journal-title":"Vaccines"},{"issue":"16","key":"7_CR74","doi-asserted-by":"publisher","first-page":"18211","DOI":"10.1021\/acsami.9b21776","volume":"12","author":"J Sharma","year":"2020","unstructured":"Sharma J, Shepardson K, Johns LL, Wellham J, Avera J, Schwarz B, Rynda-Apple A, Douglas T (2020) A self-adjuvanted, modular, antigenic VLP for rapid response to influenza virus variability. ACS Appl Mater Interfaces 12(16):18211\u201318224. https:\/\/doi.org\/10.1021\/acsami.9b21776","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"7_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44869-0","volume":"15","author":"E-C Wamhoff","year":"2024","unstructured":"Wamhoff E-C, Ronsard L, Feldman J, Knappe GA, Hauser BM, Romanov A, Case JB, Sanapala S, Lam EC, Denis KJS, Boucau J, Barczak AK, Balazs AB, Diamond MS, Schmidt AG, Lingwood D, Bathe M (2024) Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds. Nat Commun 15(1):795. https:\/\/doi.org\/10.1038\/s41467-024-44869-0","journal-title":"Nat Commun"},{"issue":"8","key":"7_CR76","doi-asserted-by":"publisher","first-page":"e0027024","DOI":"10.1128\/iai.00270-24","volume":"92","author":"GM Pyles","year":"2024","unstructured":"Pyles GM, Huckaby AB, Gutierrez M, de la P, Witt WT, Mateu-Borr\u00e1s M, Dublin SR, Rocuskie-Marker C, Sesti BN, Peasak K, Bitzer GJ, Rader N, Weaver KL, Boehm DT, Fitzgerald N, Chapman J, Ulicny S, Damron FH, Barbier M (2024) Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against Bordetella pertussis respiratory infection in mice. Infect Immun 92(8):e0027024. https:\/\/doi.org\/10.1128\/iai.00270-24","journal-title":"Infect Immun"},{"issue":"5","key":"7_CR77","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhou X, Bian Y, Wang S, Chai Q, Guo Z, Wang Z, Zhu P, Peng H, Yan X, Li W, Fu Y-X, Zhu M (2020) Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B. Nat Nanotechnol 15(5):406\u2013416. https:\/\/doi.org\/10.1038\/s41565-020-0648-y","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"7_CR78","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4161\/hv.4.3.5318","volume":"4","author":"HL Davis","year":"2008","unstructured":"Davis HL (2008) Novel vaccines and adjuvant systems: the utility of animal models for predicting immunogenicity in humans. Hum Vaccin 4(3):246\u2013250.\u2002https:\/\/doi.org\/10.4161\/hv.4.3.5318","journal-title":"Hum Vaccin"},{"key":"7_CR79","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41541-020-00221-3","volume":"5","author":"SP Graham","year":"2020","unstructured":"Graham SP, McLean RK, Spencer AJ, Belij-Rammerstorfer S, Wright D, Ulaszewska M, Edwards JC, Hayes JWP, Martini V, Thakur N, Conceicao C, Dietrich I, Shelton H, Waters R, Ludi A, Wilsden G, Browning C, Bialy D, Bhat S, Lambe T (2020) Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19. NPJ Vaccines\u20025:69.\u2002https:\/\/doi.org\/10.1038\/s41541-020-00221-3","journal-title":"NPJ Vaccines"},{"issue":"80","key":"7_CR80","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1126\/sciimmunol.ade6364","volume":"8","author":"HB Gristick","year":"2023","unstructured":"Gristick HB, Hartweger H, Loewe M, Schooten J, Ramos V, Oliveira TY, Nishimura Y, Koranda NS, Wall A, Yao KH, Poston D, Gazumyan A, Wiatr M, Horning M, Keeffe JR, Hoffmann MAG, Yang Z, Abernathy ME, Dam KMA, Bjorkman PJ (2023) CD4 binding site immunogens elicit heterologous anti\u2013HIV-1 neutralizing antibodies in transgenic and wild-type animals. Sci Immunol 8(80):6364. https:\/\/doi.org\/10.1126\/sciimmunol.ade6364","journal-title":"Sci Immunol"},{"issue":"9","key":"7_CR81","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/vaccines12091063","volume":"12","author":"K Malebo","year":"2024","unstructured":"Malebo K, Woodward J, Ximba P, Mkhize Q, Cingo S, Moyo-Gwete T, Moore PL, Williamson AL, Chapman R (2024) Development of a two-component nanoparticle vaccine displaying an HIV-1 envelope glycoprotein that elicits tier 2 neutralising antibodies. Vaccines 12(9):1063. https:\/\/doi.org\/10.3390\/vaccines12091063","journal-title":"Vaccines"},{"issue":"15","key":"7_CR82","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.3390\/ijms23158579","volume":"23","author":"JL Mej\u00eda-M\u00e9ndez","year":"2022","unstructured":"Mej\u00eda-M\u00e9ndez JL, Vazquez-Duhalt R, Hern\u00e1ndez LR, S\u00e1nchez-Arreola E, Bach H (2022) Virus-like particles: fundamentals and biomedical applications. Int J Mol Sci 23(15):8579. https:\/\/doi.org\/10.3390\/ijms23158579","journal-title":"Int J Mol Sci"},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"In: The proteomics protocols handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. In: The proteomics protocols handbook. Humana Press, New York, 571\u2013607. https:\/\/doi.org\/10.1385\/1-59259-890-0:571pp"}],"container-title":["Methods in Molecular Biology","Bioconjugation Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5112-4_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T22:05:53Z","timestamp":1785621953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5112-4_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071651117","9781071651124"],"references-count":83,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5112-4_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"4 June 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"M.R.H. is an author on patents or patent applications for Tag\/Catcher\/Ligase technologies (UK Intellectual Property Office 1002362.0, 1509782.7, 1705750.6, 1706430.4, 1903479.2, 2104999.4). M.R.H. is a co-founder and shareholder and was formerly a consultant for SpyBiotech. R.A.H. has no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}